between july 1984 and october 1987 , 21 patients with chronic myelogenous leukaemia in an accelerated or blastic phase were treated with 16 mg/kg of busulfan and 120 mg/kg of cyclophosphamide followed by infusion of bone marrow from an hla-identical sibling donor .
C0023473
chronic myelogenous
C0010583
cyclophosphamide